The pathogenesis of this condition is not well understood but it is believed to be a type IV hypersensitivity reaction that stimulates cytotoxic T cells and releases granulysin.3 The risk of disease increases in patients with malignancy, and underlying immunologic diseases.4 Here, GNLY is linked to type IV hypersensitivity disease.